Patients with liver tumours that have liver surgery performed
Conditions
Brief summary
Total opioid consumption the first 24 hours. (mg morfin equivalents)
Detailed description
Total opioid consumption the first 48 hours. (mg morfin equivalents), Postoperative intensity of pain, NRS (numerical rating scale), Complications (Clavien-Dindo), Total Intravenous Opioid consumption in the first 24 hours, and after the first 48 hours (mg morfin equivalents), Total opioid consumption by day 3, 4, 5 (mg morfin equivalenter), Time to flatus, Time to bowel movement, Nausea, vomiting, Length of stay in hospital, Mortality, Lidocaine- and MEGX-koncentration in blood immediately after induction of anestesia , 30 minutes after resection and at the end of infusion., QoR-40, adverse events
Interventions
DRUGLIDOCAINE
DRUGSODIUM CHLORIDE
Sponsors
Region Skane
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total opioid consumption the first 24 hours. (mg morfin equivalents) | — |
Secondary
| Measure | Time frame |
|---|---|
| Total opioid consumption the first 48 hours. (mg morfin equivalents), Postoperative intensity of pain, NRS (numerical rating scale), Complications (Clavien-Dindo), Total Intravenous Opioid consumption in the first 24 hours, and after the first 48 hours (mg morfin equivalents), Total opioid consumption by day 3, 4, 5 (mg morfin equivalenter), Time to flatus, Time to bowel movement, Nausea, vomiting, Length of stay in hospital, Mortality, Lidocaine- and MEGX-koncentration in blood immediately after induction of anestesia , 30 minutes after resection and at the end of infusion., QoR-40, adverse events | — |
Countries
Sweden
Outcome results
None listed